"Another mega deal hangs in the balance amid regulatory scrutiny.  Pharmacy benefit managers Express Scripts Inc. and Medco Health Solutions Inc. are awaiting word from the FTC on their $29 billion merger, which has faced criticism from consumer groups that the deal will increase drug costs."

- Gina Chon, "Global Regulators Proving Hard To Please On Mergers," The Wall Street Journal's "Deal Journal," February 1, 2012

The Wall Street Journal reported first that the advocacy group Small Business Majority has written to the Federal Trade Commission to oppose the proposed Express Scripts and Medco merger.